Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology and the Internat
![Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c86c0fb5-0da8-451e-af81-d2ade967b08e/hsr2113-fig-0004-m.jpg)
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
![PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS) PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)](https://www.researchgate.net/profile/Dirk-Larson/publication/7883288/figure/tbl2/AS:601807722127390@1520493550610/Absolute-Risk-of-Progression-of-MGUS-to-Myeloma-or-Related-Disorders-Based-on-the-Serum_Q320.jpg)
PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)
Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines
![Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis](https://www.degruyter.com/document/doi/10.1515/cclm-2015-0799/asset/graphic/j_cclm-2015-0799_fig_002.jpg)
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
![Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0d445cf1-df2f-42ed-8716-fb607cb21ea6/bjh_7456_f2.gif)
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library
Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology and the Internat
![Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/10154338-ee7f-4b52-aec0-62fdf281e1c4/hsr2113-fig-0002-m.jpg)
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
![Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis](https://www.degruyter.com/document/doi/10.1515/cclm-2015-0799/asset/graphic/j_cclm-2015-0799_fig_001.jpg)
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
Freelite® Human Kappa Free kit for use on the SPAPLUS For in vitro diagnostic use Product code: LK016.L.S
![Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance - ScienceDirect Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120531923-gr1.jpg)
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance - ScienceDirect
![Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2f33e782-175c-449a-a910-b20f370eb6ed/bjh_7456_f1.gif)
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)